225 related articles for article (PubMed ID: 24399654)
21. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
22. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
23. Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
Bamias A; Aravantinos G; Kastriotis I; Alivizatos G; Anastasiou I; Christodoulou C; Gyftaki R; Kalofonos HP; Dimopoulos MA
Urol Oncol; 2011; 29(2):189-93. PubMed ID: 19362863
[TBL] [Abstract][Full Text] [Related]
24. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
25. New onset psychosis in an adolescent during treatment of testicular germ cell tumor.
Campbell BA; Panicker J
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e125-6. PubMed ID: 21383636
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S
Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427
[TBL] [Abstract][Full Text] [Related]
27. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
28. Bleomycin in germ cell testicular tumors (GCTT).
Germa Lluch JR
Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
[No Abstract] [Full Text] [Related]
29. Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: interpretation of the current body of knowledge.
de Wit R
J Clin Oncol; 2007 Oct; 25(28):4346-9. PubMed ID: 17906198
[No Abstract] [Full Text] [Related]
30. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC
J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341
[TBL] [Abstract][Full Text] [Related]
31. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
[TBL] [Abstract][Full Text] [Related]
32. VP-16-213 (etoposide) in the management of germinal testis tumors.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
[No Abstract] [Full Text] [Related]
33. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
Stoter G
Prog Clin Biol Res; 1985; 203():437-47. PubMed ID: 2421335
[No Abstract] [Full Text] [Related]
34. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
Brada M; Horwich A; Peckham MJ
Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
[TBL] [Abstract][Full Text] [Related]
35. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
36. Cancer of the testis: a new paradigm.
Einhorn LH
Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
[No Abstract] [Full Text] [Related]
37. Experience with PVB in non seminomatous germ-cell cancer of the testis.
Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
[No Abstract] [Full Text] [Related]
38. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
[No Abstract] [Full Text] [Related]
39. Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone.
Akar E; Tural D; Arslan D; Başsorgun Cİ; Yıldız Ö
J Cancer Res Ther; 2015; 11(3):661. PubMed ID: 26458676
[TBL] [Abstract][Full Text] [Related]
40. [Modified retroperitoneal lymphadenectomy in non-seminomatous stage I, IIa and IIb testicular tumors].
Sparwasser C; Treiber U; Beckert R; Pust RA
Urologe A; 1995 Nov; 34(6):444-8. PubMed ID: 8848854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]